<?xml version="1.0" encoding="UTF-8"?>
<ref id="B134-pharmaceuticals-12-00147">
 <label>134.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kurtz</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hahnenberger</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Brooks</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Gecha</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Ingalls</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Numata</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Krystal</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: Identification of a novel inhibitor of influenza virus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>1995</year>
  <volume>39</volume>
  <fpage>2204</fpage>
  <lpage>2209</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.39.10.2204</pub-id>
  <pub-id pub-id-type="pmid">8619568</pub-id>
 </element-citation>
</ref>
